Method of determining DNA sequence preference of a DNA-binding molecule

• US 5,869,241 A
• Filed: 06/07/1995
• Issued: 02/09/1999
• Est. Priority Date: 06/27/1991
• Status: Expired due to Fees

• Current Assignee: Genelabs Technologies, Inc. (GSK plc)
• Original Assignee: Genelabs Technologies, Inc. (GSK plc)
• Inventors: Cantor, Charles R., Fry, Kirk E., Edwards, Cynthia A., Turin, Lisa M., Andrews, Beth M.
• Primary Examiner(s): TUNG, JOYCE
• Assistant Examiner(s): TUNG, JOYCE
• Application Number:
  US08/475,228
• Time in Patent Office: 1,343 Days
• Field of Search: 435/6, 435/91.1, 435/91.2, 935/77, 935/78
• US Class Current: 435/6.16
• CPC Class Codes: C07K 14/47 from mammals
• CPC Class Codes: C12N 15/1048 SELEX
• CPC Class Codes: C12N 15/67 General methods for enhancing the expression
• CPC Class Codes: C12Q 1/6811 Selection methods for production or design of target specific oligonucleotides or binding molecules
• CPC Class Codes: C12Q 1/6813 Hybridisation assays
• CPC Class Codes: C12Q 1/6876 Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
• CPC Class Codes: C12Q 1/6883 for diseases caused by alterations of genetic material
• CPC Class Codes: C12Q 1/701 Specific hybridization probes
• CPC Class Codes: C12Q 1/705 for herpetoviridae, e.g. herpes simplex, varicella zoster
• CPC Class Codes: C12Q 2521/301 Endonuclease
• CPC Class Codes: C12Q 2522/101 Single or double stranded nucleic acid binding proteins
• CPC Class Codes: C12Q 2525/131 incorporating a restriction site
• CPC Class Codes: C12Q 2525/161 incorporating target specific and non-target specific sites
• CPC Class Codes: C12Q 2537/161 A competitive reaction step
• CPC Class Codes: H01L 2924/14 Integrated circuits

Abstract

The present invention defines a DNA:protein-binding assay useful for screening libraries of synthetic or biological compounds for their ability to bind DNA test sequences. The assay is versatile in that any number of test sequences can be tested by placing the test sequence adjacent to a defined protein binding screening sequence. Binding of molecules to these test sequence changes the binding characteristics of the protein molecule to its cognate binding sequence. When such a molecule binds the test sequence the equilibrium of the DNA:protein complexes is disturbed, generating changes in the concentration of free DNA probe. Numerous exemplary target test sequences (SEQ ID NO:1 to SEQ ID NO:600) are set forth. The assay of the present invention is also useful to characterize the preferred binding sequences of any selected DNA-binding molecule.

Claims

1. A method of determining DNA sequence preference of a DNA-binding molecule, comprising

(i) adding to a mixture of duplex DNA test oligonucleotides a test molecule to be screened and a DNA binding protein, each of said test oligonucleotides having a test sequence adjacent a screening sequence, wherein said screening sequence binds to said DNA binding protein with a binding affinity that is substantially independent of the DNA sequence of said test sequence, and where said mixture of duplex DNA test oligonucleotides includes a plurality of test sequences,

(ii) incubating said test molecule, said mixture of duplex DNA test oligonucleotides and said DNA binding protein for a period sufficient to permit binding of the test molecule to test sequences in the duplex DNA,

(iii) separating test oligonucleotides from test oligonucleotides bound to binding protein,

(iv) amplifying the unbound separated test oligonucleotides,

(v) repeating steps (ii) to (iv),

(vi) isolating the amplified test oligonucleotides,

(vii) sequencing the isolated test oligonucleotides,

and thereby determining the DNA sequence preference of the DNA binding molecule tested.

2. The method of claim 1, where said test sequences are selected from the group of 256 possible four base sequences composed of A, G, C and T.

3. The method of claim 1, where said constructing includes selecting test sequences from the sequences presented as SEQ ID NO:

1 to SEQ ID NO;

600.

4. The method of claim 1, wherein said mixture of duplex DNA test oligonucleotides is formed from the test sequences presented as SEQ ID NO:

1 to SEQ ID NO;

600.

5. The method of claim 1, wherein said adjacent screening and test sequences are flanked by primer sequences.

6. The method of claim 5, where the amplification steps are repeated 1-8 times.

7. The method of claim 1, wherein said amplifying is carried out by cloning the separated test oligonucleotides into a vector, passaging vectors carrying the test oligonucleotides in appropriate host cells, culturing the host, isolating the vectors, and obtaining the test oligonucleotides from the vectors.

8. The method of claim 1, where said isolating is accomplished by cloning the amplified test oligonucleotides into a cloning vector.

9. The method of claim 1, where said separating is accomplished by passing the test reaction through a filter, where said filter is capable of capturing DNA:

protein complexes but not DNA that is free of protein.

10. The method of claim 9, where said filter is a nitrocellulose filter.

11. The method of claim 1, where the DNA screening sequence is from the HSV origin of replication and the binding protein is UL9.